Acute gouty arthritis represents an inflammatory response to microcrystals of monosodium urate that precipitate in joint tissues from supersaturated body fluids or are shed from preexisting articular deposits [1] . Gout is a metabolic disease characterized by recurrent episodes of arthritis associated with the presence of monosodium urate crystals in the tissue or synovial fluid during the attack.These forms of crystal-induced arthritis usually affect peripheral joints, including knee, ankle, wrist, and metacarpophalangeal and metatarsophalangeal joints. All of them may be associated with other inflammatory, endocrine diseases [2] . The present study was done to highlight the relationship between increased levels of uric acid and specific laboratory tests in order to possible forecast development of further disease in patients with gouty arthrithis.The present study was done on 34 patients hospitalized in Felix Hospital of Rehabilitation in 2015-2016, with age between 44 and 74, having the main diagnosis of gouty arthritis.We studied the following laboratory tests:urea and other related analysis, like uric acid, creatinine, cholesterol, glutamate pyruvate transaminase and glutamate oxalate transaminase.
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Acute gouty arthritis represents an inflammatory response to microcrystals of monosodium urate that precipitate in joint tissues from supersaturated body fluids or are shed from preexisting articular deposits [1] . Gout is a metabolic disease characterised by recurrent episodes of arthritis associated with the presence of monosodium urate crystals in the tissue or synovial fluid during the attack. These forms of crystal-induced arthritis usually affect peripheral joints, including knee, ankle, wrist, and metacarpophalangeal and metatarsophalangeal joints. All of them may be associated with other inflammatory, endocrine diseases [2] .
Gout -is a chronic disorder caused by the uric acid metabolism disorder that is clinically manifested by recurrent arthritis and the formation of subcutaneous buttocks (tofu) formed from accumulations of monosodic ureic microcrystals [4] .
Global data on epidemiological information show that hyperuricemia occurs in 5% of males and 2-3% of women worldwide but only 10% of subjects with hyperuricemia will develop gout. Family predisposition is detectable in 30% of cases [4, 5] .
In Europe, 0.3% of the population is affected with gout, but in North America only about 0.27% [6.7] . In United Kingdom, gout disease research shows that the prevalence rate of this disease is 1.39%, of which women suffer 3.6: 1 compared to men, this rate decreasing to women during premenopause. The index of the spread for the disease is higher among older people aged 75 years -> 7% for men and > 4% for females [5, 7] .
Experimental part Materials and methods
All patients who participated in the study were volunteers and gave their written consent by signing free * email: trandafirescu.cristina@umft.ro # Authors with equal contribution informed consent, and the study population was selected according to the inclusion and exclusion criteria. Variables used in present study are uric acid, creatinine, urea, glucose, cholesterol, triglycerides and ESR and are presented in table 1. Corresponding variables are presented also as follows:
Uric acid results from the degradation of nucleic acids, representing the final product of purine metabolism. Urinary acid overproduction occurs in the following situations: excessive catabolism of nucleic acids (gout), mass production and destruction of cells (leukemia) or inability to excrete the final product (renal failure) [8] .
Creatinine is creatine anhydride (methylguanidyl acetic acid) and is its release form; Is formed in muscle tissue. A disruption of renal function reduces creatinine excretion, causing elevated serum creatinine. Thus, creatinine concentrations provide an approximation of the glomerular filtration rate [9] .
Urea is the main final nitrate product of amino acid metabolism, derived from stomach and intestinal cleavage of proteins under the action of proteolytic ferments and their absorption through the intestinal wall [10] [11] [12] .
Glucose -is the most important monosaccharide in the blood. It results from the digestion of carbohydrates and the hepatic conversion of glycogen into glucose. Glucagon accelerates the conversion of glycogen into glucose and thus increases blood glucose [10] [11] [12] ALT, alanine aminotransferase or glutamyltransaminase (TGP) is an enzyme that is part of the transferase class and catalyses the reversible transfer of the amino (NH2) group from an α-ketoglutarate amino acid (alanine) resulting in pyruvic acid and glutamate formation [13, 14] .
AST (TGO)aspartate aminotransferase is an enzyme that is part of the transaminase class and catalyses the transfer of the amino group from aspartate to the ketone ketoglutarate group with oxalacetic acid formation.
ESR is the rate at which the red blood cells in an anticoagulated blood sample sediment in one hour.
Sedimentation of the red blood cells occurs when erythrocytes aggregate as a column. Normally, the blood samples in the blood sample settle down slowly due to their negative surface load, which causes the adjacent cells to reject when the intercellular distance drops below a minimum. In certain diseases that cause the growth of acute phase proteins (α-globulins, fibrinogen) or immunoglobulins, the plasma proteins attach to the surface of the red blood cells and reduce the surface potential causing the aggregation of the red blood cells and increasing their sedimentation [17, 18] . As Research Metodology : the data's were taken from the Felix Hospital of Rehabilitation Variables are as follows: Y dependent variable are, CREATININE , UREA , CREATININE, GLUCOSE, CHOLESTEROL, TRIGLYCERIDES AND ESR X independent variable: URIC ACID
Statistical analysis
In the present paper an statistical analysis of the relationship between the uric acid, urea, URIC ACID , UREA , CREATININE, GLUCOSE, CHOLESTEROL, TRIGLYCERIDES AND ESR is done . Calculations of statistical values for the variables chosed in simulations are Mean, Median, Standard Deviation, Simply variation Coefficient, Skewness Coeffficient of assymetry, Kurtosis Coefficient, Analysis of clouds of points -MEAN The average value -arithmetic mean is determined by reporting the sum of the individual values of the variable to the total number of units in the population and is calculated with the following relation [3] :
The mean value calculated for the variable x is represented on the second line in table 2 The number of noticedobservations is 34 (k = 34). (values were obtained with the EVIEWS.8 SOFTWARE )
-MEDIAN Median -The median value is that variable's level for which the number of units between the minimum value of the variable and the median is equal to the number of units between the median value and the maximum value.
The median value is calculated using relationships [3] :
, if the population volume, N, is an odd number, , if the population volume is an even number.
The median value is recorded on the third line of table 2 with results.
Where the results obtained using the Eviews software are recorded:
-the median value for the X (uric acid) variable obtained using the Eviews software is 6.75. It can be argued that for half of the patients studied, uric acid is between 2.3 and 6.7 and in the other half between 6.7 and the maximum value is 14.10;
-the mean value for Y (cholesterol) obtained using the Eviews software is 212.5. It can be said that for half of the patients studied, cholesterol ranges between 39.569 and 212.5 and in the other half between 212.5 and the maximum value being 307.56;
-the mean value for Y (creatinine) obtained using the Eviews software is 1.8. It can be argued that half of the patients studied had creatinine between the minimum value of 1.5 and the median 1.8 and in the other half between 1.8 and the maximum value being 2.7;
-the mean value for Y (glycemia) obtained using the Eviews software is 88.0. It can be argued that half of the patients studied have a blood glucose level between 20.88 and 88.0, and the other half between 88.0 and the maximum value being 167.220;
-the mean value for the Y (TGP) variable obtained using the Eviews software is 156,500. It can be said that for half of the patients studied, TG ranges from 81.263 to 156.500 and in the other half between 156.500 and the maximum value being 506.450; -the mean value for the Y variable ( TGO ) obtained using the Eviews software is 48.230. It can be argued that for half of the patients studied, the TGO ranges between the minimum value of 31.83and the median value of 48.230 and in the other half between 48.230 and the maximum value being 130;
-the mean value for the Y variable (TGP) obtained using the Eviews software is 52,405. It can be argued that for half of the patients studied, the TGP ranges between the minimum value of 37,970 and the median value of 52,405 and in the other half between 52,405 and the maximum value being 267;
-the mean value for the Y variable (UREA) obtained using the Eviews software is 35,500. It can be said that for half of the patients studied UREA ranges between the minimum value 11.491 and the median value 35.500 and in the other half between 35.500 and the maximum value recorded is 76.47;
-the mean value for the Y variable (ESR) obtained using the Eviews software is 20,000. It can be said that for half of the patients studied, the ESR ranges between the minimum value of 2.0 and the median value of 20.000 and in the other half between 20.000 and the maximum value that is 85.000.
Standard variation coefficient
The average square deviation (Std.Dev.) -the mean square deviation of a variable is determined by extracting radically from the dispersion, and the dispersion of a variable is the mean value of the squares of variance variations of the variable from the mean value. For the calculation of the dispersion is used the following relation [3] :
And the mean square deviation is calculated with the relationship:
From simulations we obtained the deviation value of the square root for variable x and for the y variable are represented on line 6 of table 2 with statistical data.
The average pedestrian deviation is the variation of the mean to average values.
Simply variation coefficent
The simple coefficient of variation -is calculated using the ratio between the mean square deviation and the mean value [3] :
The simple coefficient of variation is used to study the homogeneity of the series, as follows:
-If C v <40% the considered series is homogeneous; -If the C v > 40% series is not homogeneous. For the variable X (uric acid), the simple coefficient of variation is C v = 34.563% <40%, so we can conclude that the X series considered is a non-homogeneous series For the Y variable (cholesterol) the simple coefficient of variation is C v = 22.699% and we conclude that the series considered: cholesterol is a non-homogeneous series. The same can be said for creatinine, glycemia and urea.
For the variable Y (TG) the simple coefficient of variation is Cv = 42.182%> 40% and we conclude that the series considered: TG is a non-homogeneous series. The same can be said in case of calculations, TGO, TGP and ESR.
Skewness coefficient of assimetry
The coefficient of assimmetry (Skewness) is calculated by the relationship [3] :
We can study the variation of the asymmetry of the series considered:
-If α <0 -we have a negative asymmetry -If α = 0 the series is symmetrical -If α> 0 the asymmetry is positive, which is even more pronounced as á is further than 0.
For the X -uric acid variable, using the software, the value is obtained. α = 0.724> 0
We are dealing with a positive asymmetry For the Y (cholesterol) variable, using the software, the value is obtained. α = -1.0318 <0
We are dealing with a negative asymmetry. All other Y variables considered have positive values, so we have in each case the positive asymmetries.
The results obtained from the software calculations give the values recorded in table 2 on line 7 (Cv%). 
Kurtosis coefficient
The coefficient of curvature (Kurtosis) is calculated with the relationship [19] :
The following interpretation can be made:.
-If β4> 3-Gauss's bell is smaller than the histogram obtained with the Eviews software, the variable considered is Leptocurbal -β4 <3 -Gauss's bell is higher than the histogram -the variable is Platicurbive
With the EViews software the value is obtained -for the variable X (uric acid) the obtained value β4 = 4.716> 3 -we have the case of a leptocurbal variable -for the variable Y (cholesterol) the value obtained β4 = 6.113> 3 -we have the case of a leptocurbinal variable. We can also say about blood glucose, TG, TGO, TGP, urea and ESR -for the Y variable (creatinine) the value obtained β4 = 1.5 <3 -we have the case of a platicurbive variable. We can also say about calcium.
Analysis of points cloud
Analysis of Points cound give us the form of connection. The appearance of the cloud of points gives us the way the points are placed on the graph because there is a link between the variables.
The more clustered the points are, the stronger the link. The closer the points are, the weaker the link.
If the width of the cloud is small, the intensity is large between the variables If the cloud width is large, the intensity is small between the X and Y variables
The meaning of the link are as follows:
The link can be direct: if Y increases with X's growth The link can be inverse: if the cloud is oriented right up and down
Fisher test
Fisher test is done to determine the type of the relashionship which can be low, medium or strong intensity.
The characteristic equation for the relashionship can be a polinom of 6-th degrees Y = Ax 6 + Bx 5 + CX 4 + DX 3 +Ex 2 + Fx + G Fig. 1c,d -If Fcalc <Ftab -there is no link between variables at the total data -Fcalc> Ftab -there is a link between variables at the total data level. Conclusion: In our case, it seems that there is always a link between the data considered, and the intensity of the link increases Fcalc. In table 4 are the values of Fcalc. Table 3 gives the coefficients A, B, ..., G for the regression equations attached to the variables considered.
Durbin watson test
Durbin Watson test is done to verify the independence assumptions.
All the results obtained by applying the Durbin Watson test are in table 4.
Durbin Watson Test is Used to stop if the dependency model of the variables considered, obtained by simulation can be used in predictions or not.
The hypotheses emitted are: H0: Errors are independent H1: Errors are dependent DWcal for each variable: uric acid, urea, compares with d 1 = 1.72 and d 2 = 1.75 of the Durbin-Watson distribution table depending on a convenient choice between 0.05 and 0.01, depending on the exogenous number of k = 1 And the observed values T = 34. The rule for decision after applying the Durbin Watson Test is presented in table 5.
When we have positive autocorrelated errors, the considered model can not be used in Forecasts When the errors are neglected, the considered model can be used in the forecasting 
Discussions and conclusions
In this paper we presented a study on the biostatistical analysis of URIC ACID, CREATININE, UREA, GLICEMIA, COLESTEROL, TRIGLICERIDE AND ESR and their association with gout arthritis. We calculated and explained for the selected data set the Average value, Median value, Average square deviation, Simple variation coefficient, Skewness and Kurtosis coefficient and was done a Point cloud analysis.Some statistical models have been created.
ESR-URIC ACID, UREA-URIC ACID:, GLUCOSE -URIC ACID:, CHOLESTEROL -URIC ACID:, CREATININE -URIC ACID, TG-URIC ACID, TGO-URIC ACID, TGP-URIC ACID.
It has come to the conclusion that there is a strong link between TGO, TGP and creatinine and uric acid. Also, there are average concentrations of urea, TG and uric acid and TG and uric acid. There are weaknesses between ESR, blood glucose and cholesterol and uric acid, which can also be seen in figure 1 where the cloud of dots is represented. Some statistical models have been created that are good for future forecasting purposes.
The Durbin Watson test was performed and conclusions were drawn regarding the positive or negative autocorrelation mode of the errors and the possibility that the considered model can be used in predictions.
The study concluded that ESR -URIC ACID, UREA-URIC ACID: GLUCOSE-URIC ACID: CHOLESTEROL URIC ACID: are models that have been imposed in the present study as polynomial addicts of the 6th order.
There are strong connection between hyperuricaemia, gout and type 2 diabetes, insulin resistance and metabolic syndrome. This demonstrates the colossal importance for doctors and patients alike to assign gout a red flag for increased cardiovascular risk.
The therapy management in gout targets all three stages of the disease, the acute attack, decreasing excessive uric acid levels to prevent burns of gout arthritis and prevent the deposition of urate tissue and also the prophylaxis of acute flares. It is essential to make the difference between the specific therapy needed in order to reduce acute inflammation and the therapy which controls levels of hyperuricaemia in patients with chronic gouty arthritis [23] .
The main goal of long-term therapy is to lower the serum urate levels in order to help the dissolution of monosodium urate crystals, to reduce recurrent acute gout attack, to stop storage of sodium urate crystals monohydrate aggregates (tophi) deposited in and around the joints, to prevent joint damage and functional incapacity. According to the 2012 American College of Rheumatology (ACR) Guideline, ULT( urate lowering therapy) is indicated for the following conditions: 1) frequent gout attacks (two or more gout attacks/year), 2) clinically detectable tophi, 3) joint damage from gout, 4) concomitant urate nephrolithiasis, or 5) concurrent chronic kidney disease (stages 2-5, or end stage renal disease).A treat-to-target strategy to achieve serum urate level, 6 mg/dL is recommended for all the above patients who do not have clinically signs of tophi or erosive arthritis.Urate level , 5 mg/dL is recommended to improve the symptoms and signs of gout for patients with more severe gout.The ACR Guideline recommends monitoring serum urate level every 2-5 weeks during ULT dose escalation until the target level is achieved and at least once yearly thereafter (more frequently if the gout symptoms remain active). [20, 22] The European League Against Rheumatism (EULAR) established the recommendations for the management of gout for clinical practice published in 2016, which contain 3 general principles and 11 key recommendations as following:Patient education about the pathophysiology of the disease, about its treatment and comorbidities is essential. Understanding the principles of managing acute attacks and eliminating urate crystals by lifelong lowering of the serum urate (SU) below a target level is very important. Guidance about diet, weight, important risk factors, lifestyle, as well as the management of comorbidities is useful. For the treatment of flares, colchicine, nonsteroidal anti-inflammatory drugs (NSAIDs), and oral or intraarticular steroids, or a combination thereof, are recommended. For the patients which present frequent flares and have contraindications to colchicine, NSAIDs, and corticosteroids, an interleukin-1 blocker should be taken in consideration. Urate-lowering therapy (ULT) needs to be discussed from the first presentation and SU levels need to be maintained at levels under 6 mg/dL (360µmol/ L), or under 5 mg/dL (300 µmol/L) for those with severe gout. Allopurinol is recommended as first-line ULT with dose adjustment according to renal function. If the SU target cannot be achieved with allopurinol, then febuxostat, a uricosuric, or combining a xanthine oxidase inhibitor with a uricosuric should be considered. All ULTs should be started at low dose and titrated upwards until the SU target is achieved. Unless contraindicated, flare prophylaxis with low-dose colchicine or with NSAIDs at low dosage is recommended during the first 6 months of ULT [21] .
Although we have the ACR and EULAR guidelines which recommend the treat-to-target strategy for the management of hyperuricemia, there are different factors, such as patient compliance, inadequate patient education, lack of adherence or deficiency in primary care, that often contribute to poor monitoring and thereby treatment targets may not be achieved.
Gout arthritis is associated with important painful redness and swelling of the affected joints and thereby with reduced quality of life. During the acute gouty attack NSAIDs should be administrated immediately and are preferred associated withnon-pharmacological means such as topical ice andresting of affected joints. [23] Data in literature shows that gout is associated with significant morbidity and often asymptomatic hyperuricemia has been shown that increases the risk for cardiometabolic and chronic kidney disease. In April 2017 a study made on Japanese adults showed that asymptomatic hyperuricemia (defined as >7 mg/dL in men and e"6 mg/dL in women) was associated with increased cumulative incidence of hypertension, dyslipidemia, chronic kidney disease and overweight/obesity [24] .
In order to obtain improved outcome in patients with gout, it is needed to initiate prophylactic anti-inflammatory medication when starting ULT, monitoring urate serum levels, frequent follow-ups and improved patient education, in order to give a better adherence to therapy.
